Free Trial
OTCMKTS:CRLBF

Cresco Labs 5/15/2024 Earnings Report

Cresco Labs logo
$1.25 -0.16 (-11.54%)
As of 03:59 PM Eastern

Cresco Labs EPS Results

Actual EPS
-$0.02
Consensus EPS
-$0.02
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Cresco Labs Revenue Results

Actual Revenue
$184.30 million
Expected Revenue
$183.31 million
Beat/Miss
Beat by +$990.00 thousand
YoY Revenue Growth
N/A

Cresco Labs Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Cresco Labs' next earnings date is estimated for Friday, November 14, 2025, based on past reporting schedules.

Conference Call Resources

Cresco Labs Earnings Headlines

Cresco Labs Rallies On Renewed Hope Of Rescheduling
URGENT: The Market's 3 Red Flags Are Flashing
The warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gold price (signaling fear), and escalating geopolitical risk. A sharp correction might happen tomorrow, and most investors will be caught off guard. Your portfolio is currently exposed.tc pixel
See More Cresco Labs Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cresco Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cresco Labs and other key companies, straight to your email.

About Cresco Labs

Cresco Labs (OTCMKTS:CRLBF) is a vertically integrated, multi-state cannabis operator in the United States. The company engages in the cultivation, manufacturing and distribution of a broad range of cannabis products, including flower, pre-rolled joints, concentrates, vaporizers, edibles and tinctures. Cresco Labs’ operations span cultivation facilities, processing laboratories and a network of wholesale distribution centers that supply licensed dispensaries and retail outlets across key cannabis markets.

The company’s product portfolio is organized under several branded platforms, such as MÜV, Reserve and High Supply, each designed to address different segments of the adult-use and medical cannabis markets. Cresco Labs also operates retail dispensaries under the Sunnyside banner, providing consumers with standardized dispensary experiences and educational resources aimed at promoting responsible consumption. In addition to branded consumer products, the company offers white-label manufacturing and distribution services to third-party cannabis operators seeking scalable production solutions.

Founded by industry veterans Charlie Bachtell and Joe Caltabiano, Cresco Labs traces its origins to a 2013 cultivation and processing venture in Illinois. Since rebranding as Cresco Labs, the company has pursued a growth-through-acquisition strategy, adding licensed operations in states such as Florida, Pennsylvania, Massachusetts, Michigan, California, Colorado, Ohio, Nevada and Arizona. Key acquisitions have included regional producers and dispensary chains, enabling Cresco Labs to establish a diversified footprint and centralized supply chain infrastructure.

Under its leadership team, Cresco Labs emphasizes rigorous quality control, regulatory compliance and operational efficiency. The company maintains in-house scientific teams to oversee product development and analytical testing, ensuring consistency across its market portfolio. With expanding retail and wholesale channels, Cresco Labs aims to support long-term market growth by balancing consumer-driven innovation with adherence to evolving state regulations.

View Cresco Labs Profile

More Earnings Resources from MarketBeat